Orthofix Medical Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Orthofix Medical Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $2.48M, a 13.00% decline year-over-year.
- Orthofix Medical Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $27.00K.
- Orthofix Medical Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $2.85M, a 128.78% increase year-over-year.
- Orthofix Medical Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $49.00K.
- Orthofix Medical Inc. stock issued during period, value, new issues for fiscal 2025 was $5.50M, a 481.69% increase from fiscal 2024.
- Orthofix Medical Inc. stock issued during period, value, new issues for fiscal 2024 was $945.00K, a 29.45% increase from fiscal 2023.
- Orthofix Medical Inc. stock issued during period, value, new issues for fiscal 2023 was $730.00K, a 72.01% decline from fiscal 2022.
- Orthofix Medical Inc. stock issued during period, value, new issues for fiscal 2022 was $2.61M, a 58.40% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $2.48M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $5.50M 10-K · filed 2026-02-24 | |
| 2025-09-30 | $27.00K 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $2.85M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $49.00K 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $945.00K 10-K · filed 2026-02-24 | |
| 2024-09-30 | -$1.05M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $1.24M 10-Q · filed 2025-11-04 | |
| 2024-03-31 | -$1.83M 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $730.00K 10-K · filed 2026-02-24 | |
| 2023-09-30 | -$167.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $1.17M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | -$1.96M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $2.61M 10-K · filed 2025-02-25 | |
| 2022-09-30 | -$79.00K 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $1.08M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | -$69.00K 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $6.27M 10-K · filed 2024-03-05 | |
| 2021-09-30 | $1.21M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $1.22M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $1.62M 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $5.11M 10-K · filed 2023-03-06 | |
| 2020-09-30 | -$919.00K 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $1.92M 10-Q · filed 2021-11-05 | |
| 2020-03-31 | $812.00K 10-Q · filed 2021-11-05 | |
| 2019-12-31 | $6.36M 10-K · filed 2022-02-25 | |
| 2019-09-30 | -$663.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | -$819.00K 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $4.03M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $3.67M 10-K · filed 2021-02-26 | |
| 2018-09-30 | -$576.00K 10-Q · filed 2019-10-28 | |
| 2018-06-30 | $179.00K 10-Q · filed 2019-10-28 | |
| 2018-03-31 | $3.86M 10-Q · filed 2019-10-28 | |
| 2017-12-31 | $3.98M 10-K · filed 2020-02-24 | |
| 2016-12-31 | $17.31M 10-K · filed 2019-02-25 | |
| 2015-12-31 | $3.70M 10-K · filed 2018-02-26 | |
| 2014-12-31 | $10.46M 10-K · filed 2017-02-27 | |
| 2013-12-31 | $3.45M 10-K · filed 2016-02-29 | |
| 2012-12-31 | $25.59M 10-K · filed 2015-04-29 | |
| 2011-12-31 | $20.11M 10-K/A · filed 2015-03-31 | |
| 2010-12-31 | $7.85M 10-K/A · filed 2014-03-24 | |
| 2009-12-31 | $18.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |